State of the Art: Concise ReviewA Translational View of the Molecular Pathogenesis of Lung Cancer
Under an Elsevier user license
open archive
Key Words
Lung cancer
Molecular pathogenesis
Tyrosine kinase inhibitor
Clinic
Targeted therapy
Early detection
Prevention
Epidermal growth factor receptor
Cited by (0)
Disclosure: JDM has a research grant from Astra Zeneca to study their new drugs preclinically. The authors declare no other conflict of interest.
Copyright © 2007 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.